跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10 条关于
“Zervimesine”
全部
10
临床试验
1
药物
0
机构
0
资讯
9
去年
Cognition Therapeutics Develops Enhanced Manufacturing Process for Alzheimer's Drug Candidate Zervimesine
去年
Zervimesine Shows Promise in Geographic Atrophy Trial, Building on Success in Multiple CNS Disorders
去年
Zervimesine Shows Promise in Dry AMD Treatment with Positive Phase 2 Data
去年
Cognition Therapeutics Receives FDA Endorsement for Alzheimer's Drug Zervimesine Phase 3 Trial Design
去年
Cognition Therapeutics Secures $30 Million to Advance Alzheimer's Drug Zervimesine into Phase 3 Development
去年
Cognition Therapeutics Reveals Promising Biomarker Strategy for Alzheimer's Treatment Patient Selection
去年
Cognition Therapeutics CEO to Present Alzheimer's and DLB Progress at Upcoming Conferences
10个月前
Dry AMD Market Set for Significant Growth Through 2034 as Novel Therapies Advance in Clinical Development
去年
Cognition Therapeutics' CT1812 Shows Promise in Phase 2 Trials for Alzheimer's and Lewy Body Dementia